Biomaxima (WAR:BMX) Accounts Payable & Accrued Expense : zł3.59 Mil (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Biomaxima Accounts Payable & Accrued Expense?

Biomaxima's quarterly accounts payable & accrued expense declined from Sep. 2023 (zł3.70 Mil) to Dec. 2023 (zł3.44 Mil) but then increased from Dec. 2023 (zł3.44 Mil) to Mar. 2024 (zł3.59 Mil).

Biomaxima's annual accounts payable & accrued expense declined from Dec. 2021 (zł5.13 Mil) to Dec. 2022 (zł3.86 Mil) and declined from Dec. 2022 (zł3.86 Mil) to Dec. 2023 (zł3.44 Mil).

Biomaxima Accounts Payable & Accrued Expense Historical Data

The historical data trend for Biomaxima's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomaxima Accounts Payable & Accrued Expense Chart

Biomaxima Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

5.67

6.02

5.13

3.86

3.44

Biomaxima Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															4.60	3.01	3.70	3.44	3.59

Biomaxima Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Biomaxima (WAR:BMX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomaxima SA (WAR:BMX) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

944:Germany

Address

5 Vetterow Street, Lublin, POL, 20-277

Website

http://www.biomaxima.com

Biomaxima SA is a Polish company, produces microbiology media as well as a wide range of reagents and in Vitro diagnostics equipment. The company is also a distributor of products of recognized global diagnostics companies such as Nova Biomedical, Mitsubishi Chemical and Biologist. Its products include Systems Antibiotic Susceptibility Testing, Urine Analysis Systems, Hematological Reagents along with Analyzers, ion Selective Analyzers with Reagents, Immunological Analyzer of Cardiac markers with reagents, Glucose Meters and analyzers for Gasometric and Critical Blood Tests.

Biomaxima (WAR:BMX) Headlines

No Headlines